Myriad Genetics (MYGN)

Create an Alert
26.44 -0.18  -0.68%   NASDAQ Jun 18, 5:00PM BATS Real time Currency in USD
View Full Chart
MYGN Price Chart
    View All Performance Charts

    MYGN Total Returns Comparison

    This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Myriad Genetics is up 11.66% over the last year vs S&P 500 Total Return up 25.82%, Conceptus up 65.09%, and Haemonetics Corporation up 21.69%.

    MYGN Fundamentals

    Fundamental analysis of a business involves analyzing its financial statements and health, its management and competitive advantages. The key financial statements of a company are the income statement, balance sheet and cash flow statement.

    Income Statement View Statement

    Balance Sheet View Statement

    Get Quote for

    Pro Report PDF for MYGN

    Download Pro Ratings, Key Stats, Performance Charts, Valuations, and Financials in an easy to print format.

    Download MYGN Pro Report PDF

    Pro Strategies Featuring MYGN

    Did Myriad Genetics make it into our Pro Portfolio Strategies?
    Start your YCharts Pro membership now to find out.

    MYGN Profile

    Sector: Healthcare
    Industry: Diagnostics & Research

    Myriad Genetics, Inc. is a molecular diagnostic company based in Salt Lake City, Utah. Myriad employs a number of proprietary technologies that permit doctors and patients to understand the genetic basis of human disease and the role that genes play in the onset, progression and treatment of disease. This information is used to guide the development of new molecular diagnostic products that assess an individual's risk for developing disease later in life (predictive medicine), identify a patient's likelihood of responding to a particular drug therapy and tailor a patient's drug dose to ensure optimal treatment (personalized medicine), and assess a patient's risk of disease progression and disease recurrence (prognostic medicine). The company was founded in May 1991 and is headquartered in Salt Lake City, Utah.

    Recent Quotes

    Symbol Price Chg Chg % Market Cap
    MYGN 26.44 -0.18 -0.68% 2.105B
    Create Watchlist from Quotes

    Access watchlists and custom data alerts.
    Start your free account.

    Registering enables you to view unlimited pages per month.

    required
    required
    required
    required
    Get Started Now

    Already registered? Sign in here.

    document.write('');